Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07643220
PHASE1
Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions
Sponsor: AJU Pharm Co., Ltd.
View on ClinicalTrials.gov
Summary
To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.
Official title: An Open-Label, Randomized, Fasting, Single-Dose, Two-Sequence, Two-Period Crossover Study to Evaluate the Bioequivalence of "AJU-G721" and "G721R" in Healthy Adult Male Subjects
Key Details
Gender
MALE
Age Range
19 Years - 54 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-06
Completion Date
2026-07
Last Updated
2026-06-12
Healthy Volunteers
Yes
Interventions
DRUG
Test Drug
AJU-G721
DRUG
Reference Drug
G721R
Locations (1)
Bumin Hospital
Seoul, South Korea